Joseph E. Bugaj

1.3k total citations
34 papers, 1.1k citations indexed

About

Joseph E. Bugaj is a scholar working on Radiology, Nuclear Medicine and Imaging, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joseph E. Bugaj has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Biomedical Engineering and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joseph E. Bugaj's work include Radiopharmaceutical Chemistry and Applications (10 papers), Nanoplatforms for cancer theranostics (8 papers) and Click Chemistry and Applications (6 papers). Joseph E. Bugaj is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (10 papers), Nanoplatforms for cancer theranostics (8 papers) and Click Chemistry and Applications (6 papers). Joseph E. Bugaj collaborates with scholars based in United States, Ireland and Poland. Joseph E. Bugaj's co-authors include Richard B. Dorshow, Samuel Achilefu, Raghavan Rajagopalan, Jack L. Erion, Michelle Schmidt, Ananth Srinivasan, Elizabeth Webb, Jason S. Lewis, Carolyn J. Anderson and Ralf Wilhelm and has published in prestigious journals such as Clinical Cancer Research, Journal of Medicinal Chemistry and International Journal of Cancer.

In The Last Decade

Joseph E. Bugaj

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph E. Bugaj United States	15	529	361	250	248	191	34	1.1k
Josefine Reber Germany	19	620 1.2×	374 1.0×	131 0.5×	134 0.5×	222 1.2×	27	1.2k
Thomas D. Harris United States	17	665 1.3×	357 1.0×	588 2.4×	182 0.7×	208 1.1×	42	1.8k
Jamey P. Weichert United States	25	670 1.3×	643 1.8×	529 2.1×	448 1.8×	399 2.1×	110	2.1k
Deborah W. McCarthy United States	7	1.0k 2.0×	148 0.4×	222 0.9×	401 1.6×	323 1.7×	7	1.4k
Davina J. Honess United Kingdom	21	357 0.7×	256 0.7×	521 2.1×	232 0.9×	212 1.1×	49	1.3k
Karen E. Linder United States	18	739 1.4×	146 0.4×	257 1.0×	346 1.4×	262 1.4×	34	1.2k
Diana Möckel Germany	17	194 0.4×	383 1.1×	387 1.5×	160 0.6×	132 0.7×	33	1.4k
Humphrey Fonge Canada	23	614 1.2×	427 1.2×	574 2.3×	310 1.3×	233 1.2×	67	1.5k
R K Jain United States	13	276 0.5×	425 1.2×	772 3.1×	335 1.4×	164 0.9×	24	1.7k
Terry L. Sharp United States	21	997 1.9×	90 0.2×	391 1.6×	264 1.1×	299 1.6×	33	1.7k

Countries citing papers authored by Joseph E. Bugaj

Since Specialization

Citations

This map shows the geographic impact of Joseph E. Bugaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Bugaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Bugaj more than expected).

Fields of papers citing papers by Joseph E. Bugaj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph E. Bugaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Bugaj. The network helps show where Joseph E. Bugaj may publish in the future.

Co-authorship network of co-authors of Joseph E. Bugaj

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph E. Bugaj. A scholar is included among the top collaborators of Joseph E. Bugaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph E. Bugaj. Joseph E. Bugaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bugaj, Joseph E. & Richard B. Dorshow. (2022). Absence of developmental or reproductive toxicity in rats for MB-102, a fluorescent tracer agent for point-of-care measurement of glomerular filtration rate. Regulatory Toxicology and Pharmacology. 131. 105158–105158. 5 indexed citations

Bugaj, Joseph E. & Richard B. Dorshow. (2022). Evaluation of Developmental and Reproductive Toxicity in Rabbits for MB-102, a Fluorescent Tracer Agent Designed for Real-Time Measurement of Glomerular Filtration Rate. International Journal of Toxicology. 41(5). 380–388. 4 indexed citations

Dorshow, Richard B. & Joseph E. Bugaj. (2019). Next tier in vitro and in vivo nonclinical studies further elucidating the safety and toxicity profile of MB-102, a novel fluorescent tracer agent for measurement of glomerular filtration rate. Regulatory Toxicology and Pharmacology. 107. 104417–104417. 14 indexed citations

McKinley, Eliot T., Joseph E. Bugaj, Ping Zhao, et al.. (2011). 18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer. Clinical Cancer Research. 17(10). 3332–3340. 41 indexed citations

Aziz, Emad F., et al.. (2006). Novel Approach in Radionuclide Tumor Therapy: Dose Enhancement by High Z-Element Contrast Agents. Cancer Biotherapy and Radiopharmaceuticals. 21(3). 181–193. 7 indexed citations

Achilefu, Samuel, Richard B. Dorshow, Joseph E. Bugaj, et al.. (2002). Synthesis, In Vitro Receptor Binding, and In Vivo Evaluation of Fluorescein and Carbocyanine Peptide-Based Optical Contrast Agents. Journal of Medicinal Chemistry. 45(10). 2003–2015. 106 indexed citations

Lewis, Jason S., Mu Wang, Richard Laforest, et al.. (2001). Toxicity and dosimetry of177Lu-DOTA-Y3-octreotate in a rat model. International Journal of Cancer. 94(6). 873–877. 51 indexed citations

Bugaj, Joseph E., Jack L. Erion, Michael A. Johnson, Michelle Schmidt, & Ananth Srinivasan. (2001). Radiotherapeutic efficacy of 153Sm-CMDTPA-Tyr3-octreotate in tumor-bearing rats☆. Nuclear Medicine and Biology. 28(3). 327–334. 21 indexed citations

Achilefu, Samuel, et al.. (2001). <title>New approach to optical imaging of tumors</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 4259. 110–114. 4 indexed citations

10.

Bugaj, Joseph E., Samuel Achilefu, Richard B. Dorshow, & Raghavan Rajagopalan. (2001). Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. Journal of Biomedical Optics. 6(2). 122–122. 128 indexed citations

11.

Achilefu, Samuel, Richard B. Dorshow, Joseph E. Bugaj, & Raghavan Rajagopalan. (2000). Tumor specific fluorescent contrast agents. Proceedings of SPIE - The International Society for Optical Engineering. 3917. 80–86. 1 indexed citations

12.

Achilefu, Samuel, Richard B. Dorshow, Joseph E. Bugaj, & Raghavan Rajagopalan. (2000). Novel Receptor-Targeted Fluorescent Contrast Agents for In Vivo Tumor Imaging. Investigative Radiology. 35(8). 479–485. 250 indexed citations

13.

Achilefu, Samuel, Richard B. Dorshow, Joseph E. Bugaj, & Raghavan Rajagopalan. (2000). <title>Tumor-specific fluorescent contrast agents</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3917. 80–86. 3 indexed citations

14.

Jong, Marion de, Wout A. P. Breeman, Bert F. Bernard, et al.. (2000). [DOTA,Tyr3]octreotate, labeled with 177Lu, is most promising for radionuclide therapy of somatostatin receptor-positive tumors. Nuclear Medicine Communications. 21(6). 569–569. 8 indexed citations

15.

Wible, James H., Jolette K. Wojdyla, Joseph E. Bugaj, & Gary H. Brandenburger. (1998). Effects of Inhaled Gases on the Ultrasound Contrast Produced by Microspheres Containing Air or Perfluoropropane in Anesthetized Dogs. Investigative Radiology. 33(12). 871–879. 9 indexed citations

16.

Reubi, Jean Claude, Beatrice Waser, Jean‐Claude Schaer, et al.. (1998). Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo. European Journal of Nuclear Medicine and Molecular Imaging. 25(5). 481–490. 71 indexed citations

17.

Bugaj, Joseph E., et al.. (1997). Thixotropy of Highly Viscous Sodium (Carboxymethyl)cellulose Hydrogels. Journal of Pharmaceutical Sciences. 86(11). 1283–1287. 19 indexed citations

18.

Rajagopalan, Raghavan, et al.. (1997). Preparation, Characterization, and Biological Evaluation of Technetium(V) and Rhenium(V) Complexes of Novel Heterocyclic Tetradentate N₃S Ligands. Bioconjugate Chemistry. 8(3). 407–415. 25 indexed citations

19.

Bugaj, Joseph E., et al.. (1989). Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)—II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 16(3). 313–317. 4 indexed citations

20.

Bugaj, Joseph E., et al.. (1984). The Effect of DM SO Treatment on the Performance of [99mTc]HEDP. International Journal of Nuclear Medicine and Biology. 11(2). 109–111. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact